SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-073449
Filing Date
2024-06-20
Accepted
2024-06-20 16:58:14
Documents
1
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2417570-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2417570-4_4seq1.xml 4 5802
  Complete submission text file 0001104659-24-073449.txt   7485
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ARIAD PHARMACEUTICALS 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Schlesinger Sarah J. (Reporting) CIK: 0001579873 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 241057232